Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Metabolism

Items 21-30 of 45

Page
per page
  1. ML 281
    B5750 ML 281
    Target: STK
    Summary: serine/threonine kinase STK33 inhibitor
      Soluble in DMSO
  2. SB 747651A dihydrochloride
    B5660 SB 747651A dihydrochloride
    Summary: mitogen- and stress-activated kinase 1 (MSK1) inhibitor
      <20.77 mg/mL
  3. PIR 3.5
    B5541 PIR 3.5
    Summary: negative control of IPA 3, a Pak1 inhibitor
      ≥33.6 mg/mL
      insoluble in H2O
  4. 3PO
    B4939 3PO
    Summary: inhibitor of the PFKFB3 isozyme
      insoluble in H2O; ≥39.6 mg/mL
  5. Lomitapide
    B4885 Lomitapide
    Summary: MTP inhibitor, orally active
      ≥22.4 mg/mL
  6. Ro 48-8071 fumarate
    B4860 Ro 48-8071 fumarate
    Summary: Oxidosqualene cyclase inhibitor
      Soluble in DMSO
  7. Ro 48-8071
    B4859 Ro 48-8071
    Summary: Oxidosqualene cyclase inhibitor
      ≥14.6 mg/mL
  8. FPH2 (BRD-9424)
    B4753 FPH2 (BRD-9424)
     1 Citation
    Summary: inducer of proliferation of primary human hepatocytes
      ≥35.4 mg/mL
  9. DL-threo-2-methylisocitrate sodium
    B1310 DL-threo-2-methylisocitrate sodium
    Summary: Substrate of isocitrate lyase 1(ICL1)
      Soluble in DMSO
  10. Oxonic acid potassium salt
    B1154 Oxonic acid potassium salt
    Summary: Uricase inhibitor
      insoluble in EtOH; insoluble in DMSO; ≥19.5 mg/mL

Items 21-30 of 45

Page
per page
Relate Categories
Specificity
  1. Selective1 item
Target
  1. STK1 item
Reported Experiments
  1. Cell Experiments2item